A 78-year-old woman with permanent non-valvular atrial fibrillation is reviewed in general practice. She has hypertension and type 2 diabetes but no history of stroke or valvular disease. Her CHA2DS2-VA score is 3, renal function is normal, and there are no contraindications to anticoagulation. Which option is the most appropriate for stroke prevention?